Clinical data from the real world: Efficacy analysis of ceritinib (450mg) in ALK-rearrangement non-small-cell lung cancer patients with brain metastases in China

  • Ke Wang

Press/Media

Period20 May 2022

Media coverage

1

Media coverage

  • TitleClinical data from the real world: Efficacy analysis of ceritinib (450mg) in ALK-rearrangement non-small-cell lung cancer patients with brain metastases in China
    Media name/outletCancerJournal.net
    Country/TerritoryIndia
    Date20/05/22
    URLhttps://www.cancerjournal.net/text.asp?2022/18/2/516/345525
    PersonsKe Wang